A window-of-opportunity study with atezolizumab and the oncolytic virus pelareorep in early breast cancer (REO-027, AWARE-1)

Manso et al, Previously presented at the 2020 Virtual San Antonio Breast Cancer Symposium® – 43rd Annual Meeting;  San Antonio, TX, USA; December 9-11, 2020